Sortera Bio
PrivateLast Round
Pre Seed
May 1, 2024
Total Funding Raised
$9.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sortera Bio is a biotechnology company that operates a biologics discovery platform to accelerate drug development through AI-powered screening technology.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sortera Bio Comparables
Compare Sortera Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Antiverse | 82% | |
| A-Alpha Bio | 81% | |
| Onava | 81% | |
Sortera Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | May 1, 2024 |
Sortera Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cambridge Innovation Capital | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 29, 2026
Monthly visitors increased 84% MoM.
- Nov 26, 2024
Grew 63% QoQ from 8 to 13 employees.
Sortera Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Sortera Bio's valuation, stock price, and market status.